首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1576932

腹腔鏡設備的全球市場:洞察，競爭情形，市場預測:2030年

Laparoscopic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年10月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

2023年全球腹腔鏡設備市場規模為113.5億美元。預計到 2030 年，該市場將達到 191.3 億美元，2024 年至 2030 年的預測期內複合年增長率為 9.14%。隨著胃腸道癌和大腸癌盛行率的增加，對有效手術介入的需求也在增加。此外，由於微創手術具有眾多優點，包括縮短住院時間和降低整體醫療成本，因此世界各地越來越多地採用微創手術，從而推動了腹腔鏡設備市場的發展。此外，腹腔鏡技術的進步，例如增強的成像系統、更精確的儀器和改善手術效果的機器人輔助設備，預計將在 2024 年至 2030 年的預測期內推動腹腔鏡市場的成長。因素。

根據GLOBOCAN（2024）提供的最新數據和統計，預計2022年全球將有193萬例直腸癌新病例，預計到2045年將增加329萬例。

此外，根據國際癌症研究機構提供的最新數據（2024年），全球胃腸道癌症發生率為480萬人。

隨著全球大腸直腸癌和胃腸道癌症的發生率持續上升，人們越來越需要有效的手術解決方案，不僅能切除腫瘤，還能最大限度地減少與手術相關的身體創傷。腹腔鏡手術因其許多優點已成為許多大腸直腸癌和胃腸道癌症手術的首選方法。對於大腸直腸癌，通常進行腹腔鏡結腸切除術，涉及切除部分或全部結腸。腹腔鏡方法使外科醫生能夠非常精確地切除結腸癌區域，同時保留盡可能多的健康組織。該手術還可以使腸道功能更早恢復正常，並減少對患者生活品質的整體影響。同樣，對於胃癌等胃腸道癌症，常採用腹腔鏡胃切除術切除部分或全部胃。這種微創方法對患者特別有利，因為它可以減少手術創傷並加速術後恢復，從而擴大全球腹腔鏡設備市場。

本報告提供全球腹腔鏡設備市場相關調查，提供市場概要，以及各產品類型，各用途，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

Medtronic plc.
Stryker
Shenzen Mindray Bio Medical Electronics Co., Ltd.
Johnson & Johnson
Olympus Corporation
Intuitive Surgical.
CONMED Corporation.
Becton, Dickinson and Company
Smith & Nephew
Microline Surgical.
Optomic.
Palliare Ltd.
Sejong Medical Co., Ltd.
BIOSISHEALING
Richard Wolf GmbH.
Bolder Surgical (Hologic Inc.)
RUDOLF Medical GmbH + Co. KG.
EMOS Technology GmbH
Teleflex Incorporated.
B. Braun Melsungen AG

第9章 KOL的見解

第10章計劃的方法

第11章關於DelveInsight

第12章免責聲明和諮詢方式

簡介目錄圖表

Product Code: DIMDCL0195

Laparoscopic Devices by Product Type (Laparoscopes, Insufflators, Suction/Irrigation Pumps, Energy Devices, Trocars, and Others), Application (General Surgery, Urological Surgery, Bariatric Surgery, Gynecological Surgery, Colorectal Surgery, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increase in incidence of cancer such as gastrointestinal and colorectal cancer, growing adoption of minimally invasive surgeries across the globe, and growing advancement in laparoscopic technology.

The global laparoscopic devices market was valued at USD 11.35 billion in 2023, growing at a CAGR of 9.14% during the forecast period from 2024 to 2030, in order to reach USD 19.13 billion by 2030. As the prevalence of gastrointestinal and colorectal cancers rises, the demand for effective surgical interventions also increases. Furthermore, the growing adoption of minimally invasive surgeries across the globe due to numerous benefits, including shorter hospital stays and lower overall healthcare costs will drive the market for laparoscopic devices. Moreover, advancements in laparoscopic technology, such as enhanced imaging systems, more precise instruments, and robotic-assisted devices, which improve the outcomes of these surgeries are some of the key factors driving the growth of the laparoscopic market during the forecast period from 2024 to 2030.

Laparoscopic Devices Market Dynamics:

According to the recent data and stats provided by GLOBOCAN (2024), in 2022, globally, the estimated new cases of colerectum cancer were 1.93 million and the projections were estimated to increase 3.29 million by 2045.

Additionally, as per the recent updates provided by International Agency for Research on Cancer (2024), globally, the incidence of gastrointestinal cancer was 4.8 million.

As the incidence of colorectal and gastrointestinal cancers continues to rise globally, there is a growing need for effective surgical solutions that not only remove tumors but also minimize the physical trauma associated with surgery. Laparoscopic surgery has become the preferred approach for many colorectal and gastrointestinal cancer surgeries due to its numerous advantages. In the case of colorectal cancer, laparoscopic colectomy, which involves the removal of part or all of the colon, is a commonly performed procedure. The laparoscopic approach allows surgeons to remove the cancerous portion of the colon with high precision while preserving as much healthy tissue as possible. This technique also enables a quicker return to normal bowel function and reduces the overall impact on the patient's quality of life. Similarly, in gastrointestinal cancers, such as stomach cancer, laparoscopic gastrectomy is often used to remove part or all of the stomach. This minimally invasive approach is particularly beneficial for patients, as it reduces the surgical trauma and enhances postoperative recovery thereby escalating the overall market of laparoscopic devices across the globe.

Additionally, companies are amplifying their production of laparoscopic devices and securing regulatory approvals, thereby strategically expanding their market presence and driving further growth. For instance, in July, 2023, Genesis MedTech, announced that its ArtiSential(TM), a revolutionary series of articulating laparoscopic instruments, had successfully obtained approval from China's National Medical Products Administration (NMPA) for market release.

Thus, the factors mentioned above are likely to boost the market of laparoscopic devices during the forecasted period.

However, limitations such as reduced depth perception and visualization, and others and stringent regulatory concerns may hinder the future market of laparoscopic devices.

Laparoscopic Devices Market Segment Analysis:

In the product type segment of laparoscopic devices market the trocars are expected to hold a significant share in 2023. Trocars are playing a crucial role in boosting the overall market of laparoscopic devices due to their fundamental importance in minimally invasive surgical procedures. As a key component in laparoscopic surgery, trocars are used to create access ports through the abdominal wall, allowing surgeons to insert various instruments, including cameras and surgical tools, into the body with minimal tissue disruption. The increasing demand for laparoscopic procedures, driven by the numerous advantages of minimally invasive surgery-such as reduced postoperative pain, shorter recovery times, smaller scars, and lower risk of complications-has led to a growing need for high-quality, reliable trocars. These devices are essential for maintaining the integrity of the surgical site and ensuring the safe and efficient passage of instruments during the procedure. The market for trocars is further bolstered by continuous innovations in design and functionality, addressing specific surgical needs and improving overall outcomes. For instance, advancements in trocar technology have led to the development of bladeless, optical, and balloon-tip trocars, which minimize the risk of injury to internal organs and tissues during insertion. These improvements enhance the safety and precision of laparoscopic surgeries, making them more accessible to a broader range of patients and reducing the learning curve for surgeons. Additionally, disposable trocars are gaining popularity due to their ability to reduce the risk of cross-contamination and infection, which is increasingly important in modern healthcare settings.

For instance, in 2021, Espiner introduced the Espiner Trocar, a disposable laparoscopic trocar designed for precision and control providing safe and straightforward access to the peritoneal cavity. Thus, such strategic initiatives is poised to fuel substantial growth within the market of trocars. Hence, all the factors and product development are promoting the overall market growth of the segment thereby boosting the market of laparoscopic devices across the globe.

Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global laparoscopic devices market during the forecast period.

North America is expected to dominate the overall Laparoscopic Devices market:

North America is expected to account for the highest proportion of the laparoscopic devices market in 2023, out of all regions. This can be ascribed to the increasing prevalence of cancer such as gallbladder cancer, colorectal cancer, uterus cancer. Additionally, increasing adoption of minimally invasive surgeries, and the presence of key market players engaged in strategic activities across the region are expected to escalate the market of laparoscopic devices during the forecast period.

According to the data provided by the GLOBOCAN (2024), in 2022 the overall estimated new cases of gallbladder cancer, colorectal cancer, and uterus cancer was 279,000 in North America. As the incidence of these cancers rises, there is a growing demand for surgeries that offer effective tumor removal while minimizing patient recovery time, postoperative pain, and complications. Laparoscopic surgery, which involves the use of specialized devices to perform operations through small incisions, is particularly advantageous for these cancers. In gallbladder cancer, laparoscopic cholecystectomy allows for the precise removal of the gallbladder with less trauma to surrounding tissues. For colorectal cancer, laparoscopic colectomy and rectal surgery offer targeted removal of cancerous sections of the colon or rectum while preserving healthy tissue. In uterus cancer, laparoscopic hysterectomy enables the removal of the uterus with minimal impact on the patient's body, leading to faster recovery and fewer complications thereby escalating the overall market of laparoscopic device across the region.

Additionally, according to the American Society for Metabolic and Bariatric Surgery (2021), a total of 256,000 bariatric surgeries were performed in the United States. As the global obesity epidemic continues to rise, more individuals are turning to bariatric surgery, such as gastric bypass, sleeve gastrectomy, and adjustable gastric banding, as a viable option for long-term weight loss and the management of obesity-related conditions like type 2 diabetes, hypertension, and cardiovascular diseases. These surgeries are predominantly performed using laparoscopic techniques, which involve making small incisions through which specialized instruments, including cameras and surgical tools, are inserted. The benefits of laparoscopic bariatric surgery, such as reduced postoperative pain, shorter hospital stays, faster recovery times, and lower risk of complications, make it the preferred choice for both patients and surgeons thereby escalating the overall market across the region. Therefore, the above-mentioned factors are expected to bolster the growth of the laparoscopic devices market in the North America during the forecast period.

Laparoscopic Devices Market Key Players:

Some of the key market players operating in the laparoscopic devices market include Medtronic, Stryker, Shenzen Mindray Bio Medical Electronics Co., Ltd., Johnson & Johnson, Olympus Corporation, B. Braun Melsungen AG, Intuitive Surgical., CONMED Corporation., Becton, Dickinson and Company, Smith & Nephew, Microline Surgical., Optomic., Palliare Ltd, Sejong Medical Co., Ltd., BIOSISHEALING, Richard Wolf GmbH., Bolder Surgical (Hologic Inc.), RUDOLF Medical GmbH + Co. KG., EMOS Technology GmbH, Teleflex Incorporated., and others.

Recent Developmental Activities in the Laparoscopic Devices Market:

In June 2023, Xpan, a leading surgical instrument firm based in Canada, received approval of 510(k) from the U.S. FDA for its Universal Trocars System, which was designed to minimize tissue damage and enhance access during laparoscopic surgery.
In March 2023, Peters Surgical acquired Vectac, a France-based company, as part of its strategic expansion initiatives. This acquisition was poised to bolster Peters Surgical's product portfolio with extended product range encompassing trocars, scissors, and endoscopic forceps, particularly tailored for laparoscopic surgery to cater to the evolving needs of gynecology, urology, and visceral surgery fields.
In January 2022, Shanghai MicroPort MedBot Co., Ltd. (MicroPort(R) MedBot(R)) announced that its Toumai(R) Laparoscopic Surgical Robot (MicroPort(R) Toumai(R)) had received approval for marketing from the National Medical Products Administration (NMPA).
In October 2021, Hologic, Inc. acquired Bolder Surgical, a privately held, U.S.-based company that provides advanced energy vessel sealing surgical devices.
In April 2021, Erbe Elektromedizin acquired Maxer Endoscopy, a leading manufacturer of a wide range of endoscopic systems and instruments for laparoscopy, hysteroscopy, urology, pediatric surgery, arthroscopy, spine endoscopy, and ENT surgery.

Key Takeaways From the Laparoscopic Devices Market Report Study:

Market size analysis for current laparoscopic devices size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the laparoscopic devices market.
Various opportunities available for the other competitors in the laparoscopic devices market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current laparoscopic devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for laparoscopic devices market growth in the coming future?

Target Audience who can be Benefited From This Laparoscopic Devices Market Report Study:

Laparoscopic devices product providers
Research organizations and consulting companies
Laparoscopic devices -related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in laparoscopic devices
Various end-users who want to know more about the laparoscopic devices market and the latest technological developments in the laparoscopic devices market.

Frequently Asked Questions for the Laparoscopic Devices Market:

1. What are laparoscopic devices?

Laparoscopic devices are medical instruments that are used along with a laparoscope. These devices are made of durable materials and are available in a wide size range (3mm-10mm sizes). These instruments mainly include laparoscopes, insufflators, suction pumps, energy devices, and others.

2. What is the market for laparoscopic devices?

The global laparoscopic devices market was valued at USD 11.35 billion in 2023, growing at a CAGR of 9.14% during the forecast period from 2024 to 2030, in order to reach USD 19.13 billion by 2030.

3. What are the drivers for the laparoscopic devices market?

The laparoscopic devices market is expanding rapidly due to the rising prevalence of gastrointestinal and colorectal cancers. Furthermore, the growing adoption of minimally invasive surgeries across the globe due to numerous benefits, including shorter hospital stays and lower overall healthcare costs will drive the market for laparoscopic devices. Moreover, advancements in laparoscopic technology, such as enhanced imaging systems, more precise instruments, and robotic-assisted devices, which improve the outcomes of these surgeries are some of the key factors driving the growth of the laparoscopic market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the laparoscopic devices market?

Some of the key market players operating in the laparoscopic devices market include Medtronic, Stryker, Shenzen Mindray Bio Medical Electronics Co., Ltd., Johnson & Johnson, Olympus Corporation, Intuitive Surgical., CONMED Corporation., Becton, Dickinson and Company, Smith & Nephew, Microline Surgical., Optomic., Palliare Ltd, Sejong Medical Co., Ltd., BIOSISHEALING, Richard Wolf GmbH., Bolder Surgical (Hologic Inc.), RUDOLF Medical GmbH + Co. KG., EMOS Technology GmbH, Teleflex Incorporated., B. Braun Melsungen AG, and others.

5. Which region has the highest share in the laparoscopic devices market?

North America is expected to account for the highest proportion of the laparoscopic devices market in 2023, out of all regions. This can be ascribed to the increasing prevalence of cancer such as gallbladder cancer, colorectal cancer, uterus cancer, increase adoption of minimally invasive surgeries, and the presence of key market players engaged in strategic activities across the region are expected to escalate the market of laparoscopic devices during the forecast period.

1. Laparoscopic Devices Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Laparoscopic Devices Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Laparoscopic Devices Market Key Factors Analysis

5.1. Laparoscopic Devices Market Drivers
- 5.1.1. Increasing incidence of cancer such as gastrointestinal and colorectal cancer
- 5.1.2. Rising adoption of minimally invasive surgeries across the globe
- 5.1.3. Growing advancement in laparoscopic technology
5.2. Laparoscopic Devices Market Restraints and Challenges
- 5.2.1. Limitations associated with the devices such as reduced depth perception and visualization, and others
- 5.2.2. Stringent regulatory concerns for product approval
5.3. Laparoscopic Devices Market Opportunities
- 5.3.1. Integration of robot assisted technology in laparoscopic devices

6. Laparoscopic Devices Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Laparoscopic Devices Market Assessment

7.1. By Product Type
- 7.1.1. Laparoscopes
- 7.1.2. Insufflators
- 7.1.3. Suction/Irrigation Pumps
- 7.1.4. Energy Devices
- 7.1.5. Trocars
- 7.1.6. Others
7.2. By Application
- 7.2.1. General Surgery
- 7.2.2. Urological Surgery
- 7.2.3. Bariatric Surgery
- 7.2.4. Gynaecological Surgery
- 7.2.5. Colorectal Surgery
- 7.2.6. Others
7.3. By End-User
- 7.3.1. Hospitals
- 7.3.2. Ambulatory Surgical Centers
- 7.3.3. Others
7.4. By Geography
- 7.4.1. North America
  - 7.4.1.1. United States Laparoscopic Devices Market Size in USD Million (2021-2030)
  - 7.4.1.2. Canada Laparoscopic Devices Market Size in USD Million (2021-2030)
  - 7.4.1.3. Mexico Laparoscopic Devices Market Size in USD Million (2021-2030)
- 7.4.2. Europe
  - 7.4.2.1. France Laparoscopic Devices Market Size in USD Million (2021-2030)
  - 7.4.2.2. Germany Laparoscopic Devices Market Size in USD Million (2021-2030)
  - 7.4.2.3. United Kingdom Laparoscopic Devices Market Size in USD Million (2021-2030)
  - 7.4.2.4. Italy Laparoscopic Devices Market Size in USD Million (2021-2030)
  - 7.4.2.5. Spain Laparoscopic Devices Market Size in USD Million (2021-2030)
  - 7.4.2.6. Rest of Europe Laparoscopic Devices Market Size in USD Million (2021-2030)
- 7.4.3. Asia-Pacific
  - 7.4.3.1. China Laparoscopic Devices Market Size in USD Million (2021-2030)
  - 7.4.3.2. Japan Laparoscopic Devices Market Size in USD Million (2021-2030)
  - 7.4.3.3. India Laparoscopic Devices Market Size in USD Million (2021-2030)
  - 7.4.3.4. Australia Laparoscopic Devices Market Size in USD Million (2021-2030)
  - 7.4.3.5. South Korea Laparoscopic Devices Market Size in USD Million (2021-2030)
  - 7.4.3.6. Rest of Asia-Pacific Laparoscopic Devices Market Size in USD Million (2021-2030)
- 7.4.4. Rest of the World (RoW)
  - 7.4.4.1. Middle East Laparoscopic Devices Market Size in USD Million (2021-2030)
  - 7.4.4.2. Africa Laparoscopic Devices Market Size in USD Million (2021-2030)
  - 7.4.4.3. South America Laparoscopic Devices Market Size in USD Million (2021-2030)

8. Laparoscopic Devices Market Company and Product Profiles

8.1. Medtronic plc.
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Stryker
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Shenzen Mindray Bio Medical Electronics Co., Ltd.
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. Johnson & Johnson
- 8.4.1. Company Snapshot
- 8.4.2. Financial Overview
- 8.4.3. Product Listing
- 8.4.4. Entropy
8.5. Olympus Corporation
- 8.5.1. Company Overview
- 8.5.2. Company Overview
- 8.5.3. Company Snapshot
- 8.5.4. Financial Overview
- 8.5.5. Product Listing
- 8.5.6. Entropy
8.6. Intuitive Surgical.
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. CONMED Corporation.
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. Becton, Dickinson and Company
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Smith & Nephew
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Microline Surgical.
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. Optomic.
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. Palliare Ltd.
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. Sejong Medical Co., Ltd.
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. BIOSISHEALING
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. Richard Wolf GmbH.
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. Bolder Surgical (Hologic Inc.)
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. RUDOLF Medical GmbH + Co. KG.
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. EMOS Technology GmbH
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. Teleflex Incorporated.
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. B. Braun Melsungen AG
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy